Cargando…

Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED

CONTEXT: Hypokalemia is a common finding in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) but its exact cause often remains unknown. OBJECTIVE: To explore the prevalence and etiology of hypokalemia and the role of adrenal steroids therein in a cohort of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Borchers, Joonatan, Mäkitie, Outi, Jääskeläinen, Jarmo, Laakso, Saila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256963/
https://www.ncbi.nlm.nih.gov/pubmed/35813662
http://dx.doi.org/10.3389/fendo.2022.904507
_version_ 1784741230035337216
author Borchers, Joonatan
Mäkitie, Outi
Jääskeläinen, Jarmo
Laakso, Saila
author_facet Borchers, Joonatan
Mäkitie, Outi
Jääskeläinen, Jarmo
Laakso, Saila
author_sort Borchers, Joonatan
collection PubMed
description CONTEXT: Hypokalemia is a common finding in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) but its exact cause often remains unknown. OBJECTIVE: To explore the prevalence and etiology of hypokalemia and the role of adrenal steroids therein in a cohort of patients with APECED. METHODS: We performed a cross-sectional assessment and retrospective data collection on 44 Finnish patients with APECED to identify subjects with episodes of hypokalemia. Also 68 healthy matched controls attended the cross-sectional evaluation. Factors associating with a tendency for hypokalemia were analyzed by reviewing medical records during 1960-2021 and performing a cross-sectional analysis of serum adrenal steroids. RESULTS: In total 14 of the 44 APECED patients (32%) had episodes of hypokalemia; 2 presented with hypokalemia at cross-sectional evaluation and 12 had a history of hypokalemia before the cross-sectional evaluation. Hypokalemic episodes started at the median age of 14.1 years; 12/14 (86%) had primary adrenal insufficiency (PAI). The median number of hypokalemic periods per year was 0.3 (range 0.04-2.2); the frequency correlated positively with the number of clinical APECED manifestations at the time of cross-sectional evaluation (r=0.811, p<0.001). Etiologies of hypokalemia varied but episodes often occurred when new clinical manifestations developed and during hospitalizations. Three patients had kidney defects, also associated with electrolyte imbalances. Severity of hypokalemia varied (range 2.2-3.2 mmol/L), but no severe complications were observed. At cross-sectional evaluation, patients with PAI (n = 30) had significantly lower median plasma potassium and higher sodium concentration than controls, suggesting that fludrocortisone treatment contributed to hypokalemia. Detailed analysis of adrenal steroids provided no conclusive differences between patients with and without episodes of hypokalemia. CONCLUSIONS: In APECED, hypokalemia is common and varies in terms of frequency, etiology, and severity. PAI and kidney disease predispose to hypokalemia. In addition, hypokalemic periods seem to be more common in patients with more severe phenotype of APECED.
format Online
Article
Text
id pubmed-9256963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92569632022-07-07 Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED Borchers, Joonatan Mäkitie, Outi Jääskeläinen, Jarmo Laakso, Saila Front Endocrinol (Lausanne) Endocrinology CONTEXT: Hypokalemia is a common finding in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) but its exact cause often remains unknown. OBJECTIVE: To explore the prevalence and etiology of hypokalemia and the role of adrenal steroids therein in a cohort of patients with APECED. METHODS: We performed a cross-sectional assessment and retrospective data collection on 44 Finnish patients with APECED to identify subjects with episodes of hypokalemia. Also 68 healthy matched controls attended the cross-sectional evaluation. Factors associating with a tendency for hypokalemia were analyzed by reviewing medical records during 1960-2021 and performing a cross-sectional analysis of serum adrenal steroids. RESULTS: In total 14 of the 44 APECED patients (32%) had episodes of hypokalemia; 2 presented with hypokalemia at cross-sectional evaluation and 12 had a history of hypokalemia before the cross-sectional evaluation. Hypokalemic episodes started at the median age of 14.1 years; 12/14 (86%) had primary adrenal insufficiency (PAI). The median number of hypokalemic periods per year was 0.3 (range 0.04-2.2); the frequency correlated positively with the number of clinical APECED manifestations at the time of cross-sectional evaluation (r=0.811, p<0.001). Etiologies of hypokalemia varied but episodes often occurred when new clinical manifestations developed and during hospitalizations. Three patients had kidney defects, also associated with electrolyte imbalances. Severity of hypokalemia varied (range 2.2-3.2 mmol/L), but no severe complications were observed. At cross-sectional evaluation, patients with PAI (n = 30) had significantly lower median plasma potassium and higher sodium concentration than controls, suggesting that fludrocortisone treatment contributed to hypokalemia. Detailed analysis of adrenal steroids provided no conclusive differences between patients with and without episodes of hypokalemia. CONCLUSIONS: In APECED, hypokalemia is common and varies in terms of frequency, etiology, and severity. PAI and kidney disease predispose to hypokalemia. In addition, hypokalemic periods seem to be more common in patients with more severe phenotype of APECED. Frontiers Media S.A. 2022-06-22 /pmc/articles/PMC9256963/ /pubmed/35813662 http://dx.doi.org/10.3389/fendo.2022.904507 Text en Copyright © 2022 Borchers, Mäkitie, Jääskeläinen and Laakso https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Borchers, Joonatan
Mäkitie, Outi
Jääskeläinen, Jarmo
Laakso, Saila
Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title_full Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title_fullStr Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title_full_unstemmed Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title_short Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
title_sort recurrent hypokalemia and adrenal steroids in patients with apeced
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256963/
https://www.ncbi.nlm.nih.gov/pubmed/35813662
http://dx.doi.org/10.3389/fendo.2022.904507
work_keys_str_mv AT borchersjoonatan recurrenthypokalemiaandadrenalsteroidsinpatientswithapeced
AT makitieouti recurrenthypokalemiaandadrenalsteroidsinpatientswithapeced
AT jaaskelainenjarmo recurrenthypokalemiaandadrenalsteroidsinpatientswithapeced
AT laaksosaila recurrenthypokalemiaandadrenalsteroidsinpatientswithapeced